Statins; improving cancer survival rates; reflux and heartburn; recycling medicines.

Inside Health

BBC

Health & Fitness, Science

4.4 • 575 Ratings

🗓️ 1 July 2014

⏱️ 28 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Dr Mark Porter returns with a new series to address confusion about statins for healthy people rather than patients. Statins have hit the headlines as doctors debate the draft recommendation from NICE to lower the threshold for offering statins, which could mean millions more will be taking them.

And Mark Porter turns patient when he is investigated for persistent heartburn. Plus should GPs who miss cancers be named and shamed and why drugs can't be recycled.

Transcript

Click on a timestamp to play from that location

0:00.0	Hello, you're about to listen to a BBC podcast, and I am Ed Gamble, host of another BBC
0:04.6	podcast, The Traitors Uncloaked. But my show is available only on BBC Sounds, just like
0:09.9	Ellis and John's Saturday bonus episodes, the Pop Top Ten podcast with Scott Mills and Rylen,
0:15.0	and comedy specials from the likes of Harriet Kemsley, Susie Ruffel and Romesh Ranganathan.
0:19.9	However, and maybe I'm biased, it's really all about the traitors uncloked.
0:24.3	So for a whole bunch of exclusive scoops and podcasts, listen only on BBC Sounds.
0:29.5	Hello, I'm Dr Mark Porter and thank you for downloading this edition of Inside Health.
0:34.0	I hope you enjoy it.
0:34.9	Hello and welcome to a new series of Inside Health coming up today.
0:39.5	Improving cancer survival rates. Could naming and shaming GPs who miss cancers help reduce delays in diagnosis?
0:47.9	Health Secretary Jeremy Hunt appears to think so. Others are not so convinced. Recycling medicines.
0:53.9	The NHS wastes around £300 million every year on unused drugs, many of which are returned unopened to pharmacies. Why can't they be recycled? And reflux and heartburn. New draft guidance from Nice advises that GP should consider referring people with persistent symptoms for an endoscopy.
1:14.3	But don't most of the millions of people in the UK with reflux have persistent symptoms?
1:19.6	I know I do, so I thought I'd find out what's involved.
1:23.7	You might want to turn the volume down for this next bit.
1:27.2	It's in now. Just breathe. You all right, Mark? I tell you what, I'm never going to be a source follower. Oh, yes, you could. Ten out of ten. It wasn't too bad, it's just the gagging. More on the state of my gullet later. But first, statins. While inside Health has been off air, this cholesterol-lowering
1:45.6	family of drugs has been all over the news, and the ensuing debate among experts about who
1:51.1	should be taking them and who shouldn't has led to widespread confusion, and not just among
1:56.1	the general public. Joining me to explain why, the editor of the Drs and Therapeutic Bulletin,
2:02.1	Dr James Cave. James, this explain why, the editor of the drugs and therapeutic bulletin, Dr James Cave.
2:06.5	James, this all started when the National Institute for Health and Care Excellence.
2:09.9	Nice proposed lowering the threshold for offering statins,
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from BBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of BBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.